clonazepam has been researched along with Atrophy in 6 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vitamin B12 deficiency is a treatable cause of failure to thrive and developmental regression, involuntary movements, and anemia." | 1.39 | Involuntary movements misdiagnosed as seizure during vitamin B12 treatment. ( Belgemen, T; Carman, KB; Yis, U, 2013) |
| "Clonazepam treatment of RBD was completely or partially successful in 87% of the patients who used the drug." | 1.31 | Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. ( Boeve, BF; Olson, EJ; Silber, MH, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carman, KB | 1 |
| Belgemen, T | 1 |
| Yis, U | 1 |
| Fontenelle, LF | 1 |
| Leite, MA | 1 |
| Cersosimo, MG | 1 |
| Koller, WC | 1 |
| Fernández-Torre, JL | 1 |
| Leno, C | 1 |
| Olson, EJ | 1 |
| Boeve, BF | 1 |
| Silber, MH | 1 |
| Silfverskiöld, BP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism: a Prospective, Randomized, Double-blind and Placebo-controlled Trial[NCT02312908] | Phase 2 | 40 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for clonazepam and Atrophy
| Article | Year |
|---|---|
Involuntary movements misdiagnosed as seizure during vitamin B12 treatment.
Topics: Atrophy; Brain; Breast Feeding; Clonazepam; Diagnostic Errors; Dyskinesia, Drug-Induced; Electroence | 2013 |
Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach.
Topics: Adult; Antipsychotic Agents; Atrophy; Caudate Nucleus; Clonazepam; Clozapine; Dibenzothiazepines; El | 2008 |
Movement disorders.
Topics: Adult; Aged; Anticonvulsants; Atrophy; Brain; Child; Clonazepam; Diagnosis, Differential; Female; Hu | 2003 |
Teaching NeuroImage: Simple partial frontal status epilepticus with recurrent asymmetric tonic seizures.
Topics: Adult; Anticonvulsants; Atrophy; Clinical Protocols; Clonazepam; Drug Combinations; Electroencephalo | 2008 |
Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Aging; Anticonvulsants; Atrophy; Brain; Clonazepam; De | 2000 |
Rhythmic myoclonias including spinal myoclonus.
Topics: Animals; Arm; Atrophy; Cerebellum; Clonazepam; Electromyography; Eye Movements; Humans; Leg; Macaca | 1986 |